Trident Texofab adjourns board meeting to May 30 for FY26 results

Trident Texofab Limited adjourned its May 28, 2026, board meeting to May 30, 2026, after the Audit Committee failed to approve the audited standalone financial results for the quarter and year ended March 31, 2026, due to delays in financial statement preparation. The trading window remains closed until 48 hours after the results are made public on the new date. $TRIDENT